Home › Funds › Washington Trust Advisors, Inc. › REGN

Washington Trust Advisors, Inc. position in REGN

REGENERON PHARMACEUTICALS · Health Care

Washington Trust Advisors, Inc. reported holding 25,823 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$19.6M, representing 1.41% of its reported portfolio and ranking #19 among its reported holdings. Washington Trust Advisors, Inc. has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)25.82K sh
Reported value held$19.58M
Portfolio Weight1.41%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Washington Trust Advisors, Inc.'s REGN position evolved

Washington Trust Advisors, Inc. first disclosed a stake in REGN in Q3 2023 at 32,596 shares (US$26.8M). The position peaked in Q2 2024 at 29,485 shares, worth US$31.0M. Across 13 filings, Washington Trust Advisors, Inc. increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 25,823 shares valued at US$19.6M — a reduction of -1,880 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.60K $26.83M New
Q4 2023 32.23K $28.30M Reduce
Q1 2024 30.70K $29.54M Reduce
Q2 2024 29.48K $30.99M Reduce
Q3 2024 29.38K $30.88M Hold
Q4 2024 29.29K $20.86M Hold
Q1 2025 29.53K $18.73M Add
Q2 2025 29.96K $15.73M Add
Q3 2025 29.73K $16.71M Reduce
Q4 2025 29.42K $22.71M Reduce
Q1 2026 28.73K $22.20M Reduce
Q2 2026 27.70K $17.27M Reduce
Q3 2026 25.82K $19.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Washington Trust Advisors, Inc. held REGN?

Washington Trust Advisors, Inc. has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Washington Trust Advisors, Inc.'s current position in REGN?

As of Q3 2026, Washington Trust Advisors, Inc. holds 25.82K shares of REGN (REGENERON PHARMACEUTICALS), valued at $19.58M, representing 1.41% of its reported portfolio and ranking #19.

Has Washington Trust Advisors, Inc. been buying or selling REGN?

In the latest 13F filing (Q3 2026), Washington Trust Advisors, Inc. reduced its position in REGN. The position peaked in Q2 2024 at 29.48K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.